A Study of a Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension

Alcon

Status and phase: Completed; Phase 3

Conditions: Open-angle Glaucoma; Ocular Hypertension

Treatments: Drug: Dorzolamide 20 mg/ml + Timolol 5 mg/ml eye drops, solution (COSOPT); Drug: Brinzolamide 10 mg/ml + Timolol 5 mg/ml eye drops, suspension

Study type: Interventional

Funder types: Industry

Identifiers

NCT00314171

C-05-10

Details and patient eligibility

About

The purpose of this study is to determine whether a glaucoma therapy is safe and effective in treating patients with open-angle glaucoma or ocular hypertension.

Enrollment: 437 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• 18 years or older
• Diagnosis of open-angle glaucoma or ocular hypertension
• Other protocol-defined inclusion criteria may apply

Exclusion criteria

• Under 18
• Pregnant
• Other protocol-defined exclusion criteria may apply

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

437 participants in 2 patient groups

Brinzolamide + Timolol

Experimental group

Treatment:

Drug: Brinzolamide 10 mg/ml + Timolol 5 mg/ml eye drops, suspension

Dorzolamide + Timolol

Active Comparator group

Treatment:

Drug: Dorzolamide 20 mg/ml + Timolol 5 mg/ml eye drops, solution (COSOPT)